INmune Bio Inc. (NASDAQ: INMB) Stock Information | RedChip

INmune Bio Inc. (NASDAQ: INMB) Listen to this Section


$7.11
+0.2400 ( +3.49% ) 186.4K

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.

Market Data


Open


$7.11

Previous close


$6.87

Volume


186.4K

Market cap


$141.05M

Day range


$6.87 - $7.48

52 week range


$6.50 - $14.74

Insider Ownership Transactions

Total Amount Purchased: -73,082.00 | $ -519,613.02

Date Type Amount Purchased Purchaser
2024-04-23 Sale -18028.00 Tesi Raymond Joseph
2024-04-23 Sale -18028.00 Moss David J
2024-04-23 Sale -14423.00 Lowdell Mark William
2024-04-23 Sale -29603.00 Juda Scott
2023-11-13 Buy 7000.00 Juda Scott

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 May 30, 2024
def Proxies and info statements 4 May 29, 2024
8-k 8K-related 14 May 23, 2024
8-k 8K-related 15 May 16, 2024
4 Insider transactions 1 May 16, 2024
4 Insider transactions 1 May 16, 2024
4 Insider transactions 1 May 16, 2024
4 Insider transactions 1 May 16, 2024
4 Insider transactions 1 May 16, 2024
4 Insider transactions 1 May 16, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.